Mwandishi:
Mhariri:
Imeboershwa:
ULY CLINIC
ULY CLINIC
18 Oktoba 2026, 20:11:14
Seborrheic Dermatitis Treatment
Seborrheic Dermatitis
Seborrheic dermatitis is a chronic, recurrent inflammatory skin disorder that primarily affects areas of the body rich in sebaceous (oil) glands. It is strongly associated with overgrowth of Malassezia species (a normal skin yeast), together with an abnormal inflammatory response of the skin. The condition is not contagious, not caused by poor hygiene, and is not life-threatening, but it often causes persistent itching, visible scaling, and cosmetic concerns that can affect quality of life.
Pathophysiology (Brief)
Main mechanism:
Inflammatory reaction to Malassezia species in genetically susceptible individuals.
Contributing factors:
Increased sebaceous gland activity
Overgrowth of Malassezia yeast
Individual immune response
Genetic predisposition
Cold weather and low humidity
Emotional stress
Neurological disorders (e.g., Parkinson disease)
HIV infection or other immunosuppressive conditions
Signs & Symptoms
Typical lesions:
Erythematous (red) macules and plaques
Greasy yellow or white scales
Mild to severe itching (pruritus)
Flaking of the skin (dandruff on the scalp)
Common sites:
Scalp
Face (eyebrows, nasolabial folds, beard area)
Behind the ears
Chest (sternal area)
Upper back
Axillae
Groin
Other findings:
Oily skin
Burning or irritation
Recurrent episodes with periods of remission
Cosmetic embarrassment due to visible scaling
Diagnostic Criteria
Clinical diagnosis based on:
Characteristic greasy scaling over erythematous skin
Distribution in sebaceous gland-rich areas
Chronic or recurrent course
Supporting signs:
Dandruff involving the scalp
Symmetrical distribution
Mild to moderate itching
Improvement with antifungal treatment
Investigations
Diagnosis is usually clinical.
Investigations may be considered when the diagnosis is uncertain or disease is severe.
Recommended tests
Usually no laboratory tests required
HIV testing in severe, extensive, or treatment-resistant disease
Skin scraping with potassium hydroxide (KOH) preparation if fungal infection is suspected
Special tests
Skin biopsy (rarely required)
Fungal microscopy when diagnosis is unclear
Treatment
Treatment aims to reduce inflammation, control Malassezia overgrowth, relieve symptoms, and prevent recurrence, since the condition commonly relapses.
Non-Pharmacological Treatment
Patient education about the chronic recurrent nature of the disease
Wash affected areas regularly using mild cleansers
Avoid harsh soaps and irritating skin products
Reduce emotional stress where possible
Maintain good skin hygiene
Avoid excessive scratching
Pharmacological Treatment
Skin (Face, Chest, Back, Axilla, Groin)
Clotrimazole cream (topical) — apply every 12 hours for 4–16 weeks
OR
Miconazole cream (topical) — apply every 12 hours for 4–16 weeks
AND
Hydrocortisone cream 0.5% (topical) — apply every 12 hours for 4–16 weeks
Scalp
OR
Ketoconazole shampoo — use 3 times per week for not less than 3 months
Complications
Recurrent disease
Secondary bacterial skin infection
Persistent itching
Sleep disturbance due to pruritus
Cosmetic and psychological distress
Prevention
Although seborrheic dermatitis cannot always be prevented, recurrence can be reduced by:
Regular use of medicated shampoos in affected individuals
Early treatment of flare-ups
Good skin hygiene
Avoiding harsh skin products
Managing stress
Appropriate management of underlying conditions such as HIV infection
Patient Counselling (Important)
The condition is not contagious.
It is not caused by poor hygiene.
Treatment controls symptoms but does not permanently cure the condition.
Regular treatment may be required to prevent recurrence.
Symptoms often worsen during periods of stress or cold weather.
Seek medical review if symptoms become severe, widespread, or fail to improve with treatment.
Imeandikwa;
18 Oktoba 2026, 20:09:43
